Kelix Strikes A Deal To Acquire 14 Oncology Injectables

As Company Enters Morocco By Acquiring Pharmaceutical Institute

Kelix bio has announced two deals to expand its presence in Africa. The company is set to acquire 14 oncology injectable products from Germany-based Vitane. Furthermore, Kelix has acquired Pharmaceutical Institute, a pharmaceutical company established in Rabat, to enter Morocco. The pan-African company has also invested in Malta.

Alamy
Kelix strikes two separate deals to reinforce its commitment to serve Africa and Emerging Markets • Source: Iulian Dragomir / Alamy Stock Photo

More from Deals

More from Business